SUPN · Supernus Pharmaceuticals, Inc. · Documents
$41.21
-0.02 (-0.05%)
At close · Oct 21
Return incl. dividend (before tax)
Market Cap
$2.40B
Shares
58.13M
Volume · Oct 21
1.01M
Avg daily vol (3M)
816.71K
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| DEF 14A | — | 2025-04-30 | 2025-06-16 | |
| ARS | — | 2025-04-30 | 2024-12-31 | |
| DEFA14A | — | 2025-04-30 | — | |
| 8-K | — | 2025-04-23 | — | |
| 8-K | — | 2025-02-25 | — | |
| 10-K | — | 2025-02-25 | 2024-12-31 | |
| 8-K | — | 2025-02-24 | — | |
| 8-K | — | 2025-02-18 | — | |
| 8-K | — | 2025-02-11 | — | |
| 8-K | — | 2025-02-04 | — | |
| 8-K | — | 2025-01-27 | — | |
| 8-K | — | 2024-12-20 | 2024-12-19 | |
| 8-K | — | 2024-11-04 | — | |
| 10-Q | — | 2024-11-04 | 2024-09-30 | |
| 8-K | — | 2024-10-30 | — | |
| 8-K | — | 2024-10-21 | — | |
| 8-K | — | 2024-10-17 | — | |
| 8-K | — | 2024-10-10 | — | |
| 8-K | — | 2024-08-19 | — | |
| 10-Q | — | 2024-08-06 | 2024-06-30 | |
| 8-K | — | 2024-08-06 | — | |
| 8-K | — | 2024-08-01 | — | |
| 8-K | — | 2024-07-23 | — | |
| 8-K | — | 2024-06-17 | 2024-06-14 | |
| 8-K | — | 2024-05-23 | — | |
| 8-K | — | 2024-05-09 | — | |
| 10-Q | — | 2024-05-08 | 2024-03-31 | |
| 8-K | — | 2024-05-08 | — | |
| ARS | — | 2024-04-29 | 2023-12-31 | |
| DEFA14A | — | 2024-04-29 | — | |
| DEF 14A | — | 2024-04-29 | 2024-06-14 | |
| 8-K | — | 2024-04-24 | — | |
| 8-K | — | 2024-04-24 | 2024-04-22 | |
| 8-K | — | 2024-04-08 | — | |
| 8-K | — | 2024-02-28 | 2024-02-22 | |
| 8-K | — | 2024-02-27 | — | |
| 10-K | — | 2024-02-27 | 2023-12-31 | |
| 8-K | — | 2024-02-21 | 2024-02-14 | |
| 8-K | — | 2024-02-13 | — | |
| 8-K | — | 2024-02-05 | — | |
| 8-K | — | 2023-11-08 | — | |
| 10-Q | — | 2023-11-08 | 2023-09-30 | |
| 8-K | — | 2023-11-02 | 2023-11-01 | |
| 8-K | — | 2023-10-25 | — | |
| 8-K | — | 2023-10-18 | — | |
| 8-K | — | 2023-10-10 | 2023-10-09 | |
| 8-K | — | 2023-08-21 | 2023-08-17 | |
| 8-K/A | — | 2023-08-10 | 2023-08-08 | |
| 8-K | — | 2023-08-08 | — | |
| 10-Q | — | 2023-08-08 | 2023-06-30 |
Showing 51–100 of 213 filings
Key facts
CIK
1356576
CUSIP
868459108
13F (30d)
37 filings
36 filers
Visit website
Investor relations